Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HOXA11-AS
   Synonyms HOXA11-AS, HOXA-AS5, HOXA11-AS1, HOXA11AS, HOXA11S, NCRNA00076
   Region GRCh38_7:27184518-27189293    Sequence
   Ensembl ENSG00000240990
   RefSeq NR_002795
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name serous ovarian cancer
   ICD-0-3 C56.9  M8441/3
   Methods qPCR, RNAi, Western blot, Cell proliferation assay etc.
   Sample SOC tissues, cell lines (OVCAR3, SKOV3, A2780, OVCA433, OVCA429, and TOV112D)
   Expression Pattern up-regulated
   Function Description

HOXA11as expression in cancer tissue was 77-fold higher than that of noncancerous tissue. Higher HOXA11as expression was significantly correlated with histological grade and preoperative CA125. HOXA11as overexpression in SOC cells led to increased cell proliferation, invasion, and migration. Moreover, HOXA11as was associated with the expression of genes involved in cell invasion, migration, and epithelial-mesenchymal transition (EMT), including VEGF, MMP-9, B-catenin, E-cadherin, Snail, Twist, and Vimentin.

   Pubmed ID 27737536
   Year 2016
   Title Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer.
   External Links
   Links for  HOXA11-AS GenBank       HGNC       lncrnadb       Noncode
   Links for  serous ovarian cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.